Forest Laboratories, Inc. and Gedeon Richter Announce Results from a Phase IIb Study of Cariprazine
- Details
- Category: Clinical Trials

Pandemrix data in an elderly population
- Details
- Category: GlaxoSmithKline

Boehringer Ingelheim Animal Health closes deal to acquire Animal Health Business from Pfizer
- Details
- Category: Boehringer Ingelheim

Novartis delivers strong new product momentum and operational performance
- Details
- Category: Novartis

Merck Revenues Increase by 2.7% to € 1.9 Billion
- Details
- Category: Merck Group

FDA Determines VYVANSE® was Properly Granted Five-Year Market Exclusivity
- Details
- Category: Shire

Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement
- Details
- Category: Sanofi

More Pharma News ...
- Bayer and Onyx Initiate Phase III Trial of Nexavar® in Patients with Non-Responsive Thyroid Cancer
- Bayer and Onyx Initiate Phase III Trial of Nexavar in Patients with Non-Responsive Thyroid Cancer
- Bristol-Myers Squibb Achieves Strong Sales
- The 4-T study of intensified insulin regimens shows excellent three-year glucose control
- Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent
- Pfizer Reports Third-Quarter 2009 Results
- Novartis drug Tasigna® meets primary endpoint in pivotal trial against Glivec®